Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
We asked a sampling of industry engineers and users for their perspectives on the evolution of codec designs and applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results